BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    NANO BLOOD GLUCOSE MONITOR

    MDR report key: 14632994 · Received June 7, 2022

    Report

    Report Number
    MW5110186
    Event Type
    Malfunction
    Date Received
    June 7, 2022
    Date of Event
    May 29, 2022
    Report Date
    June 4, 2022
    Manufacturer
    TAIDOC TECHNOLOGY CORPORATION
    Product Code
    NBW
    Product Problem
    Yes
    Report Source
    Voluntary report
    Reporter Location
    WY, US
    Reporter Occupation
    PATIENT
    Health Professional
    *

    Narratives

    Description of Event or Problem · 0

    I ORDERED A PRODUCT THAT CLAIMED IT WOULD HELP TRACK MY DIABETES VIA A HEADPHONE JACK ON MY (B)(6) TAB A TABLET AND THAT IT WAS APPROVED BY THE FDA. IT'S SOLD BY CENTER HEALTH THROUGH (B)(6), I SELECTED THE NANO BECAUSE IT WOULD WORK ON ANDROID PHONES AND TABLETS BUT WHEN I GOT IT AND TRIED TO GET IT TO WORK IT NEVER DID AND THE COMPANY IS REFUSING TO HONOR THEIR OWN POLICY AND REFUND ME $(B)(6). THE NANO IS A PIECE OF JUNK AND THE COMPANY WANTS ME TO PAY MORE MONEY FOR SOMETHING ELSE THAT THEY FEEL WILL FIX THE PROBLEM WITHOUT EVEN MAKING ANY ATTEMPTS AT LISTENING TO ME. I'D BE HAPPY TO SEND THE DEVICE TO YOU A LONG WITH ALL PAPERWORK. THIS COMPANY NEEDS TO BE STOPPED ESPECIALLY IF THE FDA NEVER APPROVED THE DEVICE. PLEASE GIVE A ADDRESS TO SEND YOU THE DEVICE. CENTER HEALTH NEEDS TO BE INVESTIGATED FOR CLAIMS THAT THE FDA APPROVED THEIR DEVICE. FDA SAFETY REPORT ID# (B)(4).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    324733 NANO BLOOD GLUCOSE MONITOR SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER NBW TAIDOC TECHNOLOGY CORPORATION

    Patients

    Seq Age Sex Outcome Treatment
    1 51 YR Female ADVAIR| AMDATRIPOLINE| BRIMONIDINE| BUSPIRONE| CPAP| DORZOLAMIDE HCL | GABAPENTIN | INSULIN | JARDIANCE| LATANOPROST| LISINOPRIL | MELATONIN | METOPROLOL | MULTIVITAMINS | REQUIP | VENTOLIN | VIT B12| VIT C | WARFARIN